Fosun Pharma
Search results
fosun.com. Fosun International Limited is a Chinese multinational conglomerate holding company. [4] Founded in 1992 by Guo Guangchang and four others, the company is headquartered in Shanghai and was incorporated in Hong Kong in 2004. Its Co-CEOs are Chen Qiyu and Xu Xiaoliang.
Fosun for Good, Sharing Happiness. Fosun upholds its original aspirations of developing business for good and “Contribution to Society”, endeavoring to create happier lives for families worldwide. Assisting the fight against Malaria in Africa. Call for long-term public welfare to jointly build a malaria-free world. Rural Doctors Program.
As of 31 December 2022, Fosun International’s total assets amounted to RMB823.1 billion; it received an AA MSCI ESG rating and was the only conglomerate in Greater China with such rating. Read More
Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of one billion families in health, happiness and wealth. In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK).
秉持商业向善、助天下的初心，致力于让全球家庭生活更幸福. 助力非洲抗疟. 呼吁长效公益，共建无疟疾世界. 乡村医生项目. 从健康扶贫到乡村振兴，我们守护村医，村医守护大家. 文化教育. 发掘青少年远见者，用艺术点燃爱的火花.
Fosun International: Focused Strategy to Empower the Sustainable Growth, Total Revenue up 8.7% YoY to RMB175.39 Billion in 2022. Release time: 2023-03-29 Content sourced from： Page View：299. 2022Annual Results Highlights: Total revenue for the year amounted to RMB175.39 billion, representing a year-on-year increase of8.7%.
2021 Annual Results Summary and Highlights: Total operating revenue for the year amounted to RMB161.29 billion, representing a year-on-year increase of 18%; profit attributable to owners of the parent reached RMB10.09 billion, representing a year-on-year increase of 26%;
